Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature
Saccharomyces boulardii
Fungemia
Yarrowia
DOI:
10.1016/j.mmcr.2017.02.002
Publication Date:
2017-02-23T00:01:02Z
AUTHORS (7)
ABSTRACT
Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection children. We present the case of an 8-year-old patient pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing boulardii. Caspofungin was not effective this and he treated with amphotericin B. want to emphasize that physicians should be careful about usage critically ill patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....